TY - JOUR
T1 - Telemedicine with special focus on allergic diseases and asthma—Status 2022
T2 - An EAACI position paper
AU - Smolinska, Sylwia
AU - Popescu, Florin Dan
AU - Izquierdo, Elena
AU - Antolín-Amérigo, Darío
AU - Price, Oliver J.
AU - Alvarez-Perea, Alberto
AU - Eguíluz Gracia, Ibon
AU - Papadopoulos, Nikolaos G.
AU - Pfaar, Oliver
AU - Fassio, Filippo
AU - Hoffmann-Sommergruber, Karin
AU - Dramburg, Stephanie
AU - Agache, Ioana
AU - Jutel, Marek
AU - Brough, Helen A.
AU - Fonseca, João A.
AU - Angier, Elizabeth
AU - Boccabella, Cristina
AU - Bonini, Matteo
AU - Dunn Galvin, Audrey
AU - Gibson, Peter G.
AU - Gawlik, Radoslaw
AU - Hannachi, Farah
AU - Kalayci, Ömer
AU - Klimek, Ludger
AU - Knibb, Rebecca
AU - Matricardi, Paolo
AU - Chivato, Tomás
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.
AB - Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.
KW - e-health
KW - m-health
KW - telecare
KW - telehealth
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85178469765&partnerID=8YFLogxK
UR - https://onlinelibrary.wiley.com/doi/10.1111/all.15964
U2 - 10.1111/all.15964
DO - 10.1111/all.15964
M3 - Article
C2 - 38041429
AN - SCOPUS:85178469765
SN - 0105-4538
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
ER -